An industry commentary on regulatory issues--micro...[PDA J Pharm Sci Technol. 2002 Mar-Apr] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: PDA J Pharm Sci Technol. 2002 Mar-Apr;56(2):60-4.Links

An industry commentary on regulatory issues--microbiology.

Moldenhauer JE.

Vectech Pharmaceutical Consultants, Inc., 24543 Indoplex Circle, Farmington Hills, MI 48335, USA. jmoldenhauer@vectech.com

PMID: 11977405 [PubMed - indexed for MEDLINE]

Related articles

USP general chapter <797> pharmaceutical compounding-sterile preparations.
J Nucl Med. 2004 Jun; 45(6):20N, 28N.

[J Nucl Med. 2004]
The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
J Nucl Med. 2004 Jun; 45(6):21N-6N.

[J Nucl Med. 2004]
Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
J Parenter Sci Technol. 1988 Jul-Aug; 42(4):105.

[J Parenter Sci Technol. 1988]
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
World Health Organ Tech Rep Ser. 2007; (943):1-156.

[World Health Organ Tech Rep Ser. 2007]
ReviewOfficial USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
J Pharm Biomed Anal. 2006 Jan 23; 40(1):3-15. Epub 2005 Nov 21.

[J Pharm Biomed Anal. 2006]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

An industry commentary on regulatory issues--microbiology.An industry commentary on regulatory issues--microbiology.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show